Search Within

Hematologic Malignancies Research

Formats
  1. Journal Article (1545)
  2. Meeting Abstract (1260)
  3. Review (76)
  4. Editorial (35)
  5. Book Section (32)
  6. Research Letter (26)
  7. Conference Paper (15)
  8. Correspondence (8)
  9. Guidelines (4)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3005)
  2. GSK Faculty (2450)
  3. Department of Medicine (2318)
  4. Hematologic Malignancies, Division of (2120)
  5. Sloan Kettering Institute Faculty (2052)
  6. Molecular Pharmacology and Chemistry Program Faculty (1632)

More Groups

People
  1. Michel Sadelain (586)
  2. David Scheinberg (502)
  3. Alexander Lesokhin (381)
  4. Carl Landgren (336)
  5. Renier Brentjens (286)
  6. Gabriela Chiosis (281)

More People

Years
  1. 2025 (64)
  2. 2024 (131)
  3. 2023 (175)
  4. 2022 (126)
  5. 2021 (154)
  6. 2020 (173)

More Years

Publications
  1. Blood (660)
  2. Cancer Research (117)
  3. Journal of Clinical Oncology (112)
  4. Clinical Lymphoma, Myeloma and Leukemia (84)
  5. Biology of Blood and Marrow Transplantation (80)
  6. Molecular Therapy (68)

More Publications

Publishers
  1. American Society of Hematology (700)
  2. Nature Publishing Group (375)
  3. Elsevier Inc. (291)
  4. American Association for Cancer Research (245)
  5. American Society of Clinical Oncology (116)
  6. Cell Press (116)

More Publishers

Results (3005)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimization of globin lentiviral vector design for the treatment of beta-thalassemia
    Meeting Abstract

    Lisowski, L.; Rivella, S.; Zhu, P.; Sadelain, M.
    Blood Cells, Molecules, and Diseases (2007)

    Fulltext@MSK | Save
  • Efficacy and long term survival of genetically modified T cells targeting CD19 in a syngeneic immune competent transgenic murine tumor model is dependent on prior lymphodepleting chemotherapy
    Meeting Abstract

    Lee, J.; Nikhamin, Y.; Imperato, G.; Cohen, A.; Sadelain, M.; Brentjens, R.
    Blood (2007)

    Fulltext@MSK | Save
  • Pentostatin, cyclophosphamide, rituximab, and mitoxantrone (PCRM): A new highly active regimen for patients with chronic lymphocytic leukemia (CLL) previously treated with PCR or FCR
    Meeting Abstract

    Lamanna, N.; Heaney, M. L.; Brentjens, R. J.; Jurcic, J. G.; Weiss, M. A.
    Blood (2007)

    Fulltext@MSK | Save
  • A panel of artificial antigen-presenting cells (AAPC) expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both subdominant and dominant viral-epitopes for adoptive therapy
    Meeting Abstract

    Hasan, A.; Kollen, W. J.; Selvakumar, A.; Trivedi, D.; Sadelain, M.; O'Reilly, R. J.
    Blood (2007)

    Fulltext@MSK | Save
  • Photo-reactive and non-natural amino acid Epitopes of human WT1 enhance immunogenicity and allow kinetic study of antigen processing
    Meeting Abstract

    Haro, K. J.; Gómez-Nuñez, M.; Dao, T.; Chau, D.; Won, A.; Escobar-Alvarez, S.; Zakhaleva, V.; Korontsvit, T.; Gin, D.; Scheinberg, D. A.
    Blood (2007)

    Fulltext@MSK | Save
  • The yeast Hsp110, Sse1p, binds peptide with high affinity and plays a role in clathrin function
    Meeting Abstract

    Goeckeler, J. L.; Petruso, A. P.; Aguirre, J.; Clement, C.; Chiosis, G.; Brodsky, J. L.
    FASEB Journal (2007)

    Fulltext@MSK | Save
  • Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted (TCD) hematopoietic stem cell transplants (HSCT) for the treatment of myeloid malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Papadopoulos, E.; Hsu, K. C.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; Chiu, M.; Kernan, N. A.; Prockop, S. E.; more...
    Blood (2007)

    Fulltext@MSK | Save
  • Donor killer 1G-like receptor haplotype is associated with lower relapse in chronic myelogenous leukemia patients undergoing allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Abarghoui, F.; Pinto-Agnello, C.; Gooley, T.; Senitzer, D.; Malkki, M.; Dupont, B.; Petersdorf, E.; Hsu, K.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Scalable expansion of potent genetically modified human langerhans cells in a closed system for clinical applications
    Journal Article

    Yuan, J.; Kendle, R.; Ireland, J.; Heller, G.; Sadelain, M.; Young, J. W.; Riviere, I.
    Journal of Immunotherapy (2007)

    Fulltext@MSK | Save
  • Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands
    Journal Article

    Yu, J.; Heller, G.; Chewning, J.; Kim, S.; Yokoyama, W. M.; Hsu, K. C.
    Journal of Immunology (2007)

    Fulltext@MSK | Save